Drug Search Results

Polihexanide

Alternative Names: polihexanide
Latest Update: 2024-12-16
Latest Update Note: News Article

Product Description

Mechanisms of Action: No Mechanism

Novel Mechanism: No

Modality: Nondrug

Route of Administration: Subcutaneous,Topical,Nasal

FDA Designation: Orphan Drug - Keratitis *

Approval Status: Not Approved

Approved Indications: None

Known Adverse Events: None

Company: Johannes Lauscher
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Polihexanide

Countries in Clinic:

Active Clinical Trial Count: 1

Highest Development Phases

Phase 3: Surgical Wound Infection

Trial	Phase	Trial Status	Disease	Primary Completion Date	Probability of Success
2017-000152-26	P3	Completed	Surgical Wound Infection	2022-07-27

Recent News Events

Date	Type	Title
12/16/2024	News Article	SIFI provides updates on the UK and US regulatory pathways for AKANTIOR® in the treatment of acanthamoeba keratitis
08/27/2024	News Article	Avanzanite Bioscience Reports European Commission's Authorisation of Orphan Medicinal Product AKANTIOR®
08/26/2024	News Article	SIFI Receives European Commission Approval for AKANTIOR®
06/03/2024	News Article	Avanzanite Bioscience Reports AKANTIOR® Received Positive CHMP Opinion and Announces Corporate Expansion Into 26 European Countries
05/02/2024	PubMed	Assessing antibacterial efficacy of a polyhexanide hydrogel versus alginate-based wound dressing in burns.
05/02/2024	PubMed	Safety and effectiveness of an antiseptic wound cleansing and irrigation solution containing polyhexamethylene biguanide.
05/01/2024	PubMed	Novel Effective Medical Therapy for Acanthamoeba Keratitis.

Did PRYZM just deliver the data you were looking for?
Did you try our Excel download too?

Now that you’ve used PRYZM, we hope you’re able to see for yourself that it was designed and developed by people who actually use this data for a living. By applying next-generation technology for aggregating and curating this info across multiple key sources PRYZM delivering the latest information at your fingertips just the way you need it and with industry leading speed and cost effectiveness.

Our subscribers enjoy unlimited searches and receive this data on their own secure instance so they can overlay any additional internal/proprietary data on top of the search results and blend that data with real-time industry intel from PRYZM. Discover how you can continue to uncover the competitive landscape and drive strategy.

Suggestions